Skip to main content

Advertisement

Table 1 Demographic and clinical characteristics of MS patients treated with MX

From: Cardiovascular comorbidity in multiple sclerosis patients treated with Mitoxantrone therapy: a cohort study

Variable N
Gender (W/M) 264 (158/106)
Mean age at onset (years +/- SD) 48 (10.3)
Disease course  
 RR 65 (41 D/24 U)
 SP 132 (82 D/50 U)
 PP 38 (19 D/19 U)
 PR 29 (16 D/13 U)
Mean disease duration (years, range) 11,3 (1 – 38)
Mean Follow-up (years +/- SD) 8 (3)
Mean number of MTX (range) 7,5 (1 – 21)
Mean cumulative dose/m2 (range) 70,8 (1 – 139)